XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED AWARDS AND STOCK OPTIONS
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
SHARE-BASED AWARDS AND STOCK OPTIONS SHARE-BASED AWARDS AND STOCK OPTIONS

The following table summarizes share-based compensation expense and the related income tax benefit recognized for our share-based awards and stock options:
 
Three Months Ended
 
Six Months Ended
 
June 30, 2020
 
June 30, 2019
 
June 30, 2020
 
June 30, 2019
 
 
 
 
 
 
 
 
 
(in thousands)
 
 
 
 
 
 
 
 
Share-based compensation expense
$
34,983

 
$
16,496

 
$
62,805

 
$
27,914

Income tax benefit
$
7,742

 
$
3,728

 
$
14,215

 
$
6,237


 
Share-Based Awards

The following table summarizes the changes in unvested restricted stock and performance awards for the six months ended June 30, 2020:
 
Shares
 
Weighted-Average
Grant-Date
Fair Value
 
 
 
 
 
(in thousands)
 
 
 
 
 
 
Unvested at December 31, 2019
1,844

 

$149.96

Granted
572

 
192.40

Vested
(638
)
 
119.07

Forfeited
(38
)
 
168.98

Unvested at June 30, 2020
1,740

 

$174.85



The total fair value of restricted stock and performance awards vested during the six months ended June 30, 2020 and June 30, 2019 was $76.0 million and $24.6 million, respectively.

For restricted stock and performance awards, we recognized compensation expense of $30.8 million and $14.8 million during the three months ended June 30, 2020 and 2019, respectively, and $56.0 million and $24.9 million during the six months ended June 30, 2020 and 2019, respectively. As of June 30, 2020, there were $184.2 million of unrecognized compensation expense related to unvested restricted stock and performance awards that we expect to recognize over a weighted-average period of 2.3 years.

Stock Options

The following table summarizes stock option activity for the six months ended June 30, 2020: 
 
Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
 
Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
(in thousands)
 
 
 
(years)
 
(in millions)
 
 
 
 
 
 
 
 
Outstanding at December 31, 2019
1,755

 

$74.06

 
6.5
 
$190.3
Granted
125

 
200.42

 
 
 
 
Forfeited
(2
)
 
113.48

 
 
 
 
Exercised
(484
)
 
61.77

 
 
 
 
Outstanding at June 30, 2020
1,394

 

$89.60

 
6.6
 
$115.3
 
 
 
 
 
 
 
 
Options vested and exercisable at June 30, 2020
996

 

$68.52

 
5.7
 
$100.7


We recognized compensation expense for stock options of $2.2 million and $0.9 million during the three months ended June 30, 2020 and 2019, respectively, and $4.1 million and $1.6 million for the six months ended June 30, 2020 and 2019, respectively. The aggregate intrinsic value of stock options exercised during the six months ended June 30, 2020 and 2019 was $66.5 million and $18.9 million, respectively. As of June 30, 2020, we had $12.6 million of unrecognized compensation expense related to unvested stock options that we expect to recognize over a weighted-average period of 2.0 years.

The weighted-average grant-date fair value of stock options granted during the six months ended June 30, 2020 and 2019 was $54.85 and $39.60, respectively. Fair value was estimated on the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:
 
Six Months Ended
 
June 30, 2020
 
June 30, 2019
 
 
 
 
Risk-free interest rate
1.24%
 
2.49%
Expected volatility
30%
 
30%
Dividend yield
0.39%
 
0.04%
Expected term (years)
5
 
5


The risk-free interest rate was based on the yield of a zero coupon U.S. Treasury security with a maturity equal to the expected life of the option from the date of the grant. Our assumption on expected volatility was based on our historical volatility. The dividend yield assumption was determined using our average stock price over the preceding year and the annualized amount of our most current quarterly dividend per share. We based our assumptions on the expected term of the options on our analysis of the historical exercise patterns of the options and our assumption on the future exercise pattern of options.